Top

Clinical Rheumatology

Published in:

01-02-2021 | Coronavirus | Letter to the Editor

Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic

Authors: Steffen Springer, Artur Strzelecki, Michael Zieger

Published in: Clinical Rheumatology | Issue 2/2021

Excerpt

Dear Editor, …

Dey M, Zhao SS (2020) COVID-19, and Kawasaki disease: an analysis using Google Trends. Clin Rheumatol 39:2483–2484. https://doi.org/10.1007/s10067-020-05231-zCrossRefPubMed

Freeman AF, Shulman ST (2006) Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 74(7):1141–1148PubMed

Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21:26–30. https://doi.org/10.1111/1756-185X.13218CrossRefPubMed

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB et al (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540. https://doi.org/10.1542/hpeds.2020-0123CrossRefPubMed

Waltuch T, Gill P, Zinns LE et al (2020) Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 38:2246.e3–2246.e6. https://doi.org/10.1016/j.ajem.2020.05.058CrossRef

Riphagen S, Gomez X, Gonzalez-Martinez C et al (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395:1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1CrossRefPubMedPubMedCentral

Lie Morand A, Urbina D, Fabre A (2020) COVID-19 and Kawasaki like disease: the known-known, the unknown-known and the unknown-unknown. https://doi.org/10.20944/PREPRINTS202005.0160.V1

DeBiasi RL, Song X, Delaney M et al (2020) Severe coronavirus disease-2019 in children and young adults in the Washington, DC, Metropolitan Region. J Pediatr 223:199–203.e1. https://doi.org/10.1016/j.jpeds.2020.05.007

Mahase E (2020) Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ m1710. https://doi.org/10.1136/bmj.m1710

10.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395:1771–1778. https://doi.org/10.1016/S0140-6736(20)31103-XCrossRefPubMedPubMedCentral

Title: Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic
Authors: Steffen Springer
Artur Strzelecki
Michael Zieger
Publication date: 01-02-2021
Publisher: Springer International Publishing
Keywords: Coronavirus
COVID-19
Kawasaki Disease
Kawasaki Disease
Kawasaki Disease
Published in: Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05535-0

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2021

Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis

Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis—a real-life experience

PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients

Assessment of patient satisfaction, functionality, and quality of life after ultrasound-guided knee intervention: a prospective study

Characteristics of primary Sjögren’s syndrome related lymphocytic interstitial pneumonia

Potential role of mitochondria in synoviocytes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page